Top News

Ambit Biosciences Names Venture Partner To Board

San Diego-based biopharmaceuticals firm Ambit Biosciences announced this morning that it has tapped a venture partner from New Enterprise Associates for a new board member. Ambit said it has named David R. Parkinson, M.D. to its board of directors; Parkinson also serves on the board of Threshold Pharmaceuticals and Zyngenia, in addition to previously sitting on the boards of Facet Biotech. He was previously CEO and President of Nodality become joining NEA.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel